These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22389514)

  • 21. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.
    Wahl DG; Bounameaux H; de Moerloose P; Sarasin FP
    Arch Intern Med; 2000 Jul; 160(13):2042-8. PubMed ID: 10888978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody profiles for the diagnosis of antiphospholipid syndrome.
    Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
    Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Premature cardiovascular disease: no indication for the determination of antiphospholipid antibodies or lupus anticoagulant as a possible risk factor].
    Wierema TK; Stehouwer CD
    Ned Tijdschr Geneeskd; 2007 Mar; 151(13):735-8. PubMed ID: 17471773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome.
    Pasoto SG; Chakkour HP; Natalino RR; Viana VS; Bueno C; Lianza AC; de Andrade JL; Neto ML; Fuller R; Bonfa E
    Clin Rheumatol; 2012 Sep; 31(9):1331-8. PubMed ID: 22692396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiphospholipid antibodies, lupus anticoagulant and thrombosis].
    Capel P
    Rev Med Brux; 1997 Jun; 18(3):108-10. PubMed ID: 9273597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
    Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
    Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus.
    Frijns CJ; Derksen RH; De Groot PG; Algra A; Fijnheer R
    Clin Exp Immunol; 2001 Jul; 125(1):149-54. PubMed ID: 11472438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.
    Yelnik CM; Urbanski G; Drumez E; Sobanski V; Maillard H; Lanteri A; Morell-Dubois S; Caron C; Dubucquoi S; Launay D; Duhamel A; Hachulla E; Hatron PY; Lambert M
    Lupus; 2017 Feb; 26(2):163-169. PubMed ID: 27432808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.
    Sobanski V; Lemaire-Olivier A; Giovannelli J; Dauchet L; Simon M; Lopez B; Yelnik C; Lambert M; Hatron PY; Hachulla E; Dubucquoi S; Launay D
    Front Immunol; 2018; 9():2457. PubMed ID: 30464761
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical analysis of 12 patients with pediatric antiphospholipid syndrome with pulmonary embolism].
    Ma JR; Song HM; Xiao J; Tang XY; He YY; Wei M
    Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):25-29. PubMed ID: 28072955
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical significance of antiphospholipid antibodies in Indian scleroderma patients.
    Gupta R; Thabah MM; Gupta S; Shankar S; Kumar A
    Rheumatol Int; 2009 Dec; 30(2):277-9. PubMed ID: 19701755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial lupus anticoagulant.
    Tănăseanu C; Tănăseanu S
    Roum Arch Microbiol Immunol; 1999; 58(3-4):259-65. PubMed ID: 11845463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study.
    Les I; Parraza N; Anaut P; Eguiluz S; Sánchez C; Preciado ME; Loza JÁ; Andía A
    Rheumatol Int; 2018 Feb; 38(2):229-238. PubMed ID: 29124399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.
    Stojanovich L; Kontic M; Djokovic A; Ilijevski N; Stanisavljevic N; Marisavljevic D
    Scand J Rheumatol; 2012 May; 41(3):223-6. PubMed ID: 22324785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.